Paid Clinical Trials in Connecticut

Connecticut has 1,306 paid clinical trials enrolling now across cities including New Haven, Hartford and Stamford. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 29, 2026.

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

1,161 clinical trials

↓ Download CSV

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

for Non-small Cell Lung Cancer (NSCLC)

Sites in New Haven +8 more locations

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT07349537·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in New Haven +4 more locations

Sponsor: Ottimo Pharma Limited

Sex: All·Age: 18+

Code: NCT07266428·Phase 1, Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer

for HPV Infection

Sites in New Haven +2 more locations

Sponsor: Qurasense

Sex: Female·Age: 25+·Accepts healthy volunteers

Code: NCT07281599·Recruiting·Listed Dec 2025

Apply to this trial

A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

for Platinum-resistant Ovarian Cancer

Sites in New Haven +6 more locations

Sponsor: Stemline Therapeutics, Inc.

Sex: Female·Age: 18+

Code: NCT07226427·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

Molecular Indicators of Systematic Fitness

for Healthy Adult

1 location in New Haven

Sponsor: VO Health, Inc.

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07393841·Recruiting·Listed Feb 2026

Apply to this trial

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial

for Cardiovascular Disease

Drug: Olpasiran

Sites in Bridgeport +5 more locations

Sponsor: Amgen

Sex: All·Age: 35 - 80

Code: NCT07293260·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in New Haven +5 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT07226349·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

for Breast Cancer

Sites in New Haven +5 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT07222267·Phase 1·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

for Locally Advanced Solid Tumor

Sites in New Haven +5 more locations

Sponsor: Ipsen

Sex: All·Age: 18+

Code: NCT07213817·Phase 1, Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer

for Metastatic Castration-Resistant Prostatic Cancer

1 location in New Haven

Sponsor: T.O.A.D. Oncology SA

Sex: Male·Age: 18+

Code: NCT07258407·Phase 1, Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors

for Advanced Solid Tumor

Sites in New Haven +2 more locations

Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All·Age: 18+

Code: NCT07166601·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

EVERO Drug-coated Balloon (DCB) Randomized Trial

for Peripheral Vascular Disease

Sites in New Haven +6 more locations

Sponsor: Cook Research Incorporated

Sex: All·Age: 18+

Code: NCT07144150·Recruiting·Listed Aug 2025

Apply to this trial

Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)

for Osteogenesis Imperfecta (OI)

Sites in New Haven +8 more locations

Sponsor: Angitia Incorporated Limited

Sex: All·Age: 18 - 75

Code: NCT07062588·Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

Visugromab in Cachexia International Trial

for Cancer-associated Cachexia

Sites in Norwich +7 more locations

Sponsor: CatalYm GmbH

Sex: All·Age: 18+

Code: NCT07112196·Phase 2, Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program

for Glycogen Storage Disease Type Ia

Sites in Hartford +8 more locations

Sponsor: Ultragenyx Pharmaceutical Inc

Sex: All·Age: 2+

Code: NCT06636383·Recruiting·Listed Oct 2024

Apply to this trial

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

for Age-Related Macular Degeneration

Sites in Manchester +4 more locations

Sponsor: i-Lumen Scientific AUS PTY LTD

Sex: All·Age: 60+

Code: NCT06662162·Recruiting·Listed Oct 2024

Apply to this trial

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

for Advanced Prostate Cancer

Sites in New Haven +4 more locations

Sponsor: Genentech, Inc.

Sex: Male·Age: 18+

Code: NCT05800665·Phase 1·Recruiting·Listed Apr 2023

Apply to this trial

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

for Metastatic Non-Squamous Non-Small Cell Lung Cancer

Sites in New Haven +6 more locations

Sponsor: CatalYm GmbH

Sex: All·Age: 18+

Code: NCT07098988·Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

for Squamous Non-small-cell Lung Cancer

Sites in New Haven +7 more locations

Sponsor: Alentis Therapeutics AG

Sex: All·Age: 18+

Code: NCT06747585·Phase 1, Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

for Metastatic Colorectal Cancer

Drug: Pumitamig

Sites in New Haven +3 more locations

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT07079631·Phase 1, Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

SNV1521 in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in New Haven +4 more locations

Sponsor: Synnovation Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06220864·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)

for Ovarian Cancer Recurrent

Sites in New Haven +7 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: Female·Age: 18+

Code: NCT06843447·Phase 1, Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding

for Acute Gastrointestinal Bleeding

Sites in New Haven +5 more locations

Sponsor: Medtronic - MITG

Sex: All·Age: 22+

Code: NCT06188585·Recruiting·Listed Jan 2024

Apply to this trial

ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours

for Advanced Solid Tumor

Sites in New Haven +4 more locations

Sponsor: Adcendo ApS

Sex: All·Age: 18+

Code: NCT06597721·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

for Pulmonary Hypertension Due to Lung Diseases and Hypoxia

Sites in New Haven +2 more locations

Sponsor: OrphAI Therapeutics

Sex: All·Age: 18 - 80

Code: NCT05798923·Phase 2·Recruiting·Listed Apr 2023

Apply to this trial

MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion

for Degenerative Disc Disease

Sites in Hartford +7 more locations

Sponsor: Kuros Biosurgery AG

Sex: All·Age: 18+

Code: NCT05037968·Recruiting·Listed Sep 2021

Apply to this trial

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

for Cervical Squamous Cell Carcinoma

Sites in New Haven +8 more locations

Sponsor: Alentis Therapeutics AG

Sex: All·Age: 18+

Code: NCT07169734·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

for Locally Advanced Solid Tumors

Drug: Atezolizumab

Sites in New Haven +5 more locations

Sponsor: Genentech, Inc.

Sex: All·Age: 18+

Code: NCT06031441·Phase 1·Recruiting·Listed Sep 2023

Apply to this trial

A Study of BG-C477 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in New Haven +8 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06596473·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725

for Netherton Syndrome

Sites in New Haven +4 more locations

Sponsor: BioCryst Pharmaceuticals

Sex: All·Age: 12 - 65·Accepts healthy volunteers

Code: NCT06539507·Phase 1·Recruiting·Listed Aug 2024

Apply to this trial

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

for Non-small Cell Lung Cancer

Sites in New Haven +8 more locations

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT07111520·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects

for Healthy Volunteers

1 location in New Haven

Sponsor: Intra-Cellular Therapies, Inc.

Sex: All·Age: 18 - 55·Accepts healthy volunteers

Code: NCT06299410·Phase 1·Recruiting·Listed Mar 2024

Apply to this trial

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

for Solid Tumors

Sites in New Haven +2 more locations

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT05471856·Phase 1·Recruiting·Listed Jul 2022

Apply to this trial

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

for Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency)

Sites in New Haven +2 more locations

Sponsor: Duke Street Bio Ltd

Sex: All·Age: 18+

Code: NCT06458712·Phase 1·Recruiting·Listed Jun 2024

Apply to this trial